Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Advanced Medical Solutions ( (GB:AMS) ) has provided an update.
Advanced Medical Solutions Group has confirmed that its issued share capital as of 31 March 2026 stands at 219,604,175 ordinary shares of 5p each, all carrying voting rights and with no shares held in treasury. This updated share count provides the new denominator investors must use when calculating whether their holdings trigger disclosure obligations under the U.K. Financial Conduct Authority’s transparency rules, ensuring clarity over voting power and regulatory reporting thresholds.
The clarification of total voting rights follows ongoing expansion after the Peters Surgical acquisition, which is intended to accelerate AMS’s U.S. and international growth and increase direct sales penetration. By maintaining transparent capital and voting structures while pursuing scalable growth and margin improvement, the company reinforces its governance standards and supports long-term value creation for shareholders and other stakeholders.
The most recent analyst rating on (GB:AMS) stock is a Hold with a £213.00 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.
Spark’s Take on AMS Stock
According to Spark, TipRanks’ AI Analyst, AMS is a Neutral.
The score is mainly driven by mixed financial performance: improving 2025 revenue growth and cash generation, but materially weaker margins/returns versus prior peaks and higher leverage. Technical indicators point to soft momentum with the price below key moving averages. Valuation further pressures the score due to a high P/E, with only modest support from the dividend yield.
To see Spark’s full report on AMS stock, click here.
More about Advanced Medical Solutions
Advanced Medical Solutions Group is a U.K.-based medical device company focused on tissue healing products, including adhesives, sealants, biosurgical devices and sutures for surgical and wound care markets. The group leverages advanced material science and applicator design, and is expanding globally following its acquisition of Peters Surgical, with surgical products now contributing the majority of its revenues and underpinning its growth strategy.
Average Trading Volume: 811,501
Technical Sentiment Signal: Sell
Current Market Cap: £413.3M
Find detailed analytics on AMS stock on TipRanks’ Stock Analysis page.